pharmaphorum November 2, 2023
US start-up Samay has reported clinical data showing that its Sylvee wearable device can accurately diagnose chronic obstructive pulmonary disease (COPD), and even predict potentially fatal exacerbations before they happen.
The San Francisco Bay area company – formerly known as Respira Labs – said the artificial intelligence-assisted device was able to detect ‘air trapping,’ an early predictor of COPD exacerbations, with 83% accuracy compared to hospital-based pulmonary function tests (PFTs) based on in-person spirometry and plethysmography tests or CT scans.
It also diagnosed COPD with 90% accuracy and identified statistically significant associations in medication efficacy during pre- and post-bronchodilation PFTs, according to Samay, which said it plans to publish its findings once additional patient data is available from the study.
...Today's Sponsors
Today's Sponsor